A clinical study to evaluate the effect of purnayavaniarka nebulization in wheezing childre
Phase 2
- Conditions
- Health Condition 1: J22- Unspecified acute lower respiratory infection
- Registration Number
- CTRI/2022/11/047398
- Lead Sponsor
- Parul Institute of Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of either sex.
Patients between age group of 6-14 years
Patients having wheezing on chest auscultation
Patients consenting to be included in the study
Exclusion Criteria
Known case of tuberculosis or any other acute and grave infection.
Patients with history of malignancy
Patients with congenital anatomical abnormalities of chest and respiratory system
Patients in life- threatening conditions viz,- respiratory acidosis, diabetic ketoacidosis, Respiratory Distress Syndrome etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Will assess whether Parnayavani Arka Nebulization helps in reducing symptom wheezing with the help of GINA assessment scaleTimepoint: Every 6th hour will check for the improvement of symptoms for two days and will take follow ups on 5th and 7th day
- Secondary Outcome Measures
Name Time Method Is parnayavani arka nebulization more effective than salbutamol nebulizationTimepoint: First 2 days <br/ ><br>5th day <br/ ><br>7th day